These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2406585)

  • 41. Chemopreventive properties of chlorophyllin: inhibition of aflatoxin B1 (AFB1)-DNA binding in vivo and anti-mutagenic activity against AFB1 and two heterocyclic amines in the Salmonella mutagenicity assay.
    Dashwood RH; Breinholt V; Bailey GS
    Carcinogenesis; 1991 May; 12(5):939-42. PubMed ID: 1903094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of the bacterial mutagenicity of N-methyl-N'-nitro-N-nitrosoguanidine by ascorbic acid and ascorbyl palmitate.
    Tyrsina EG; Rossikhina OG; Abilev SK; Tyrsin YuA
    Mutat Res; 1994 Apr; 321(1-2):81-7. PubMed ID: 7510849
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro anti-mutagenic effect of magnolol against direct and indirect mutagens.
    Saito J; Sakai Y; Nagase H
    Mutat Res; 2006 Oct; 609(1):68-73. PubMed ID: 16884943
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutagenicity and antimutagenicity of extracts of three spices and a medicinal plant in Thailand.
    Higashimoto M; Purintrapiban J; Kataoka K; Kinouchi T; Vinitketkumnuen U; Akimoto S; Matsumoto H; Ohnishi Y
    Mutat Res; 1993 Nov; 303(3):135-42. PubMed ID: 7694130
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimutagenicity studies of chlorophyllin using the Salmonella arabinose-resistant assay system.
    Warner JR; Nath J; Ong TM
    Mutat Res; 1991 Jan; 262(1):25-30. PubMed ID: 1898768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutagenicity and tumor-initiating activity of cyclopenta(c,d)pyrene and structurally related compounds.
    Wood AW; Levin W; Chang RL; Huang MT; Ryan DE; Thomas PE; Lehr RE; Kumar S; Koreeda M; Akagi H; Ittah Y; Dansette P; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1980 Mar; 40(3):642-9. PubMed ID: 7471084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acrylamide as an inducer of metabolic activation system (S9) in rats.
    el-Din AY; al-Maskati HA; Mohamed AY; Dairi MG
    Mutat Res; 1993 Jul; 300(2):91-7. PubMed ID: 7685498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bioactivation of promutagens by the unicellular green alga Chlamydomonas reinhardtii.
    Podstavková S; Vlcek D; Miadoková E
    J Environ Pathol Toxicol Oncol; 1997; 16(1):21-6. PubMed ID: 9256928
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differences in the hydroxylation pattern of flavonoids alter their chemoprotective effect against direct- and indirect-acting mutagens.
    Resende FA; da Silva Almeida CP; Vilegas W; Varanda EA
    Food Chem; 2014 Jul; 155():251-5. PubMed ID: 24594182
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibitory effect of phenolic compounds on aflatoxin B1 metabolism and induced mutagenesis.
    San RH; Chan RI
    Mutat Res; 1987 Apr; 177(2):229-39. PubMed ID: 3104775
    [TBL] [Abstract][Full Text] [Related]  

  • 51. UV-irradiation potentiates the antimutagenicity of p-aminobenzoic and p-aminosalicylic acids in Salmonella typhimurium.
    Gichner T; Baburek I; Velemínský J; Kappas A
    Mutat Res; 1991 Jul; 249(1):119-23. PubMed ID: 2067527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Possible mechanisms of antimutagens by various teas as judged by their effects on mutagenesis by 2-amino-3-methylimidazo[4,5-f]quinoline and benzo[a]pyrene.
    Chen HY; Yen GC
    Mutat Res; 1997 Sep; 393(1-2):115-22. PubMed ID: 9357568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA adducts and carcinogenicity of nitro-polycyclic aromatic hydrocarbons.
    Fu PP; Herreno-Saenz D; Von Tungeln LS; Lay JO; Wu YS; Lai JS; Evans FE
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):177-83. PubMed ID: 7889844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antimutagenicity of Murdannia loriformis in the Salmonella mutation assay and its inhibitory effects on azoxymethane-induced DNA methylation and aberrant crypt focus formation in male F344 rats.
    Intiyot Y; Kinouchi T; Kataoka K; Arimochi H; Kuwahara T; Vinitketkumnuen U; Ohnishi Y
    J Med Invest; 2002 Feb; 49(1-2):25-34. PubMed ID: 11901756
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
    Huang MT; Wood AW; Chang RL; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1986 Feb; 46(2):558-66. PubMed ID: 3079665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antimutagenic activity of vitamin B1 against damages induced by chemical and physical mutagens in Salmonella typhimurium and Escherichia coli.
    Sánchez-Navarrete J; Arriaga-Alba M; Ruiz-Pérez NJ; Toscano-Garibay JD
    Toxicol In Vitro; 2017 Dec; 45(Pt 1):202-206. PubMed ID: 28927723
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer preventive potential of methanol extracts of Hypsizigus marmoreus.
    Chang JS; Bae JT; Oh EJ; Kim JY; Park SH; Lee KR
    J Med Food; 2009 Jun; 12(3):493-500. PubMed ID: 19627196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Marked antimutagenic potential of aqueous green tea extracts: mechanism of action.
    Bu-Abbas A; Clifford MN; Walker R; Ioannides C
    Mutagenesis; 1994 Jul; 9(4):325-31. PubMed ID: 7968574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutagenicity and toxicity of the DNA alkylation carcinogens 1,2-dimethylhydrazine and azoxymethane in Escherichia coli and Salmonella typhimurium.
    Xiao W; Nowak M; Laferte S; Fontanie T
    Mutagenesis; 1996 May; 11(3):241-5. PubMed ID: 8671746
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Butylhydroxytoluene inhibition of the mutagenic activity of carcinogenic nitroso compounds and cyclophosphamide: the role of the glutathione conjugation reaction].
    Kalinina EV; Loknitskaia NN; Shuliakovskaia TS; Fonshteĭn LM
    Vopr Onkol; 1987; 33(9):59-63. PubMed ID: 3310399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.